US · MENS
Jyong Biotech Ltd. Ordinary Shares
- Sector
- Healthcare · Biotechnology
- Headquarters
- New Taipei City, TP 221
- Website
- jyongbio.com
Price · as of 2026-08-28
$2.37
Market cap 155.86M
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $1.98 |
Line items
Line items
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Growth | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| MENS | Jyong Biotech Ltd. Ordina… | $2.03 | 155.86M | — | — | -30.95 | -5.80 | — | -64.59 | — |
| AAPG | Ascentage Pharma Group In… | $16.86 | 391.72M | $4.89 | -71% | -11.86 | 11.06 | 26.24 | -12.93 | -43.05% |
| APGE | Apogee Therapeutics, Inc. | $134.23 | 8.31B | — | — | -17.06 | 4.83 | — | -14.33 | — |
| CELC | Celcuity Inc. | $92.92 | 4.53B | — | — | -33.90 | 59.68 | — | -36.03 | — |
| CGON | CG Oncology Inc. | $72.42 | 6.39B | $32.48 | -55% | -30.87 | 6.60 | 1230.16 | -26.54 | 254.70% |
| DYN | Dyne Therapeutics, Inc. | $26.17 | 4.89B | — | — | -5.16 | 2.37 | — | -2.77 | — |
| LEGN | Legend Biotech Corporatio… | $19.05 | 3.52B | $28.57 | +50% | -11.61 | 3.45 | 3.36 | -12.57 | 64.04% |
| RARE | Ultragenyx Pharmaceutical… | $24.93 | 2.46B | $9.58 | -62% | -3.66 | -26.30 | 3.13 | -5.67 | 20.13% |
| TVTX | Travere Therapeutics, Inc… | $62.76 | 5.84B | $36.91 | -41% | -97.08 | 21.60 | 5.05 | 111.89 | 110.45% |
| XENE | Xenon Pharmaceuticals Inc… | $64.30 | 6.22B | — | — | -12.65 | 7.52 | 583.62 | -11.21 | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $2.37) − 1 = — (IC, example).